BridgeBio Pharma Cost of Goods Sold 2018-2024 | BBIO

BridgeBio Pharma cost of goods sold for the twelve months ending December 31, 2024 was $0.005B, a 124.25% increase year-over-year.

  • BridgeBio Pharma annual cost of goods sold for 2024 was $0.004B, a 0% decline from 2024.
  • BridgeBio Pharma annual cost of goods sold for 2024 was $0.004B, a 58.54% increase from 2023.
  • BridgeBio Pharma annual cost of goods sold for 2023 was $0.002B, a 0% decline from 2023.

BridgeBio Pharma Cost of Goods Sold 2018-2024 | BBIO

  • BridgeBio Pharma annual cost of goods sold for 2024 was $0.004B, a 0% decline from 2024.
  • BridgeBio Pharma annual cost of goods sold for 2024 was $0.004B, a 58.54% increase from 2023.
  • BridgeBio Pharma annual cost of goods sold for 2023 was $0.002B, a 0% decline from 2023.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
Dr Reddy's Laboratories (RDY)$11.2B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M